|
Orthologous residues
|
|
IRS1 (human): S794‑p, IRS1 (mouse): S789‑p, IRS1 (rat): S789‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
C2C12 (myoblast)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
mouse
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
AICAR
|
|
|
|
increase
|
|
|
wortmannin
|
AICAR
|
|
|
no effect upon treatment-induced increase
|
|
|
insulin
|
AICAR
|
|
|
no effect upon treatment-induced increase
|
|
|
insulin
|
|
|
|
no change compared to control
|
|
|